# Adjuvant Radiation Therapy With Ifosfamide in Patients With Mixed Mesodermal Tumors of the Uterus

> **NCT00231842** · PHASE2 · COMPLETED · sponsor: **Montefiore Medical Center** · enrollment: 30 (actual)

## Conditions studied

- Uterine Cancer

## Interventions

- **DRUG:** Ifosfamide
- **DEVICE:** Radiation Therapy
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT00231842
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00231842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00231842, "Adjuvant Radiation Therapy With Ifosfamide in Patients With Mixed Mesodermal Tumors of the Uterus". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00231842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*